

Phage Therapy Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
The Phage Therapy market is experiencing significant growth, driven by increasing antibiotic resistance and rising demand for alternative treatments. As of 2023, the market size is projected to reach approximately $930 million, with a CAGR of around 14%. Key drivers include advancements in genetic engineering and expanded regulatory approvals. Request Sample Report
◍ Phage International
◍ Adaptive Phage Therapeutics
◍ AmpliPhi Biosciences
◍ C3J Therapeutics
◍ Enbiotix
◍ InnoPhage
◍ iNtODEWorld
◍ Intralytix
◍ Locus Biosciences
◍ Phagomed
◍ Pherecydes Pharma
◍ TechnoPhage
◍ Eligo Bioscience
◍ Phagelux
The Phage Therapy Market features companies like Phage International and Intralytix, focusing on bacteriophage treatments for antibiotic-resistant infections. These companies innovate in research and development, establishing clinical trials, and regulatory approvals, thereby expanding market reach and adoption.
Sales revenues:
- AmpliPhi Biosciences: $3 million (2021)
- Locus Biosciences: $20 million (2021) Request Sample Report
Human Medicine
Veterinary Science
Agriculture
Request Sample Report
Oral
External Application
Surgical Treatment
$ 53.60 Billion
Request Sample Report